NetworkNewsBreaks Archive - Page 2001 of 2146

ThursdaySep 28, 2017 12:22 pm

NetworkNewsBreaks – Alltemp, Inc. (LTMP) Teams Up with North Park Innovation to Improve Installation Process on the iManifold® Network

Alltemp, Inc. (OTCQB: LTMP), a developer of proprietary, environmentally friendly refrigerant technologies, recently announced that its alltemp® refrigerant data has been added to the iManifold® system interface. This move pairs two HVAC technology innovators by bringing these advancements to the global industry, allowing alltemp® users to get the most out of their alltemp® refrigerant and climate control systems. As noted in the news release, better installs result in even more efficiently running systems, which translate into greater user savings. To view the full press release, visit: http://nnw.fm/aNr2V About Alltemp, Inc. Alltemp, Inc. has developed a proprietary refrigerant technology, after years…

ThursdaySep 28, 2017 12:20 pm

NetworkNewsBreaks – Alternate Health (CSE: AHG) (OTCQB: AHGIF) Announces Launch of Cannabis Blockchain Transaction Ledger

Alternate Health Corp. (CSE: AHG) (OTCQB: AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance and appropriate usage of cannabinoids in modern medical practices, recently announced the rebranding of its CanaCard software to the CanaPass Patient Management System with the goal of integrating mobile technology and providing a blockchain ledger for the purposes of transparency and accountability. “The evolution of CanaPass is a natural step forward in Alternate Health’s software development as we continuously update and adapt the system to changes in technology," Dr. Michael Murphy, CEO of…

ThursdaySep 28, 2017 9:48 am

NetworkNewsBreaks – Skinvisible Pharmaceuticals, Inc. (SKVI) Announces Definitive Licensing Agreement with Canopy Growth Corp.

Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) this morning announced the signing of a definitive license agreement with Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF) related to Skinvisible’s patented topical formulations. Per the agreement, Canopy Growth is now exclusively licensed to distribute Skinvisible’s topical products throughout Canada and maintains first right of refusal for all other countries, excluding China and the United States. “This agreement with Canopy Growth Corporation is a significant milestone for Skinvisible,” Terry Howlett, president of Skinvisible, stated in the news release. “Canopy Growth is the leader and innovator in the cannabis space with over…

WednesdaySep 27, 2017 12:35 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 27, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: IMNP 39.39% – News: Reports positive results from ongoing phase 2 study of bertilimumab to treat BP BLPH 16.67% – News: Announces $23M private placement ASTC 15.96% – News: 1st Detect subsidiary enters cooperative R&D agreement with the DHS in support of transportation security MTSL 11.17% – News: Receives TEMIA Best Practice Award for 2017 MARK 11.05% – News: KanKan subsidiary secures a seven-figure contract with a state-owned enterprise in China PPCB 10.20% –…

WednesdaySep 27, 2017 12:34 pm

NetworkNewsBreaks – Mizuho: ViewRay, Inc. (NASDAQ: VRAY) Technology Topic of Discussion in Upcoming Industry Expert Conference Call

ViewRay (NASDAQ: VRAY) was recently covered in a U.S. Equity Research report by Mizuho Securities USA LLC. The company was issued a 'Buy' rating and price target of $12 per share. The company's technology will be part of an "Industry Expert Conference Call" taking place October 17 at 11 a.m. ET. The call will discuss "MRI guided LINAC – ViewRay’s MRidian or Elekta’s Unity?” Among others, a few topics to be covered include why MRI-LINAC is needed for radiation oncology, the decision-making process at Washington University in choosing ViewRay’s MRIdian and other relevant clinical experience. To view the full report,…

WednesdaySep 27, 2017 12:03 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Net Element, Inc. (NASDAQ: NETE)

SeeThruEquity updated coverage on Net Element, Inc. (NASDAQ: NETE) this week following release of the company’s earnings report for the second quarter of 2017. Net Element reported second quarter revenue of $16.1 million, representing an 18% increase from the second quarter of 2016. The analyst noted that this impressive performance was primarily attributed to the company’s NA Transactions segment, which saw revenue growth of 31% YoY. The company’s Online Solutions segment also displayed hearty growth from a small base with a revenue increase of 33% YoY. Additionally, the analyst noted that the company has been given until October 20, 2017,…

WednesdaySep 27, 2017 12:00 pm

NetworkNewsBreaks – Mizuho Securities Initiates Coverage with ‘Buy’ Rating on Heron Therapeutics, Inc. (NASDAQ: HRTX)

Mizuho Securities USA LLC has initiated coverage with a ‘Buy’ rating and price target of $28 on shares of Heron Therapeutics, Inc.’s (NASDAQ: HRTX) stock. The company currently has two drugs in development in the chemotherapy-induced nausea and vomiting (CINV) space. Its lead product, Sustol, is in the commercial stage, while Cinvanti is up for approval in November 2017. Heron expects to launch Cinvanti in the first quarter of 2018. The analyst believes that the company’s potential to have two CINV drugs targeting two sides of a $900 million market is underappreciated and predicts that Heron will reach break-even in…

WednesdaySep 27, 2017 11:59 am

NetworkNewsBreaks – Nektar Therapeutics (NASDAQ: NKTR) Receives ‘Buy’ Rating from Mizuho Securities

Mizuho Securities USA LLC has initiated coverage with a ‘Buy’ rating and price target of $30 on shares of Nektar Therapeutics’ (NASDAQ: NKTR) stock. Mizuho analysts believe Nektar’s immuno-oncology candidate NKTR-214 is the company’s most valuable asset, as it could provide significant upside while the company’s royalty-generating portfolio maintains a more consistent revenue stream for the biotech company. Additionally, Nektar has formed collaborations with numerous pharmaceutical companies on its PEGylation platform, which also provides a predictable revenue stream and a stable foundation. For more information, visit www.Nektar.com About Nektar Nektar Therapeutics is a research-based development stage biopharmaceutical company with a…

WednesdaySep 27, 2017 9:30 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Announces Acquisition of PotSaver

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”), has finalized a majority ownership acquisition of PotSaver, a revenue-producing community periodical providing listings on discounted cannabis-related products for Southern California dispensaries and shops. Per this morning’s update, the majority ownership acquisition is expected to provide MTRAC with an immediate revenue stream related to PotSaver’s existing subscription-based earnings. “The majority ownership acquisition of PotSaver marks a significant milestone for MoneyTrac Technology,” Vanessa Luna, COO of MTRAC, stated in the news release. “Not only does it provide our company with an…

TuesdaySep 26, 2017 3:36 pm

NetworkNewsBreaks – Pivot Pharmaceuticals (PVOTF) and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

Pivot Pharmaceuticals (OTCQB: PVOTF) and its medical cannabis product division, Pivot Green Stream Health Solutions, recently announced the signing of a definitive agreement with Solmic Research GmbH (Germany) which gives Pivot Pharmaceuticals worldwide rights to Solmic Solubilisation Technology for the development and commercialization of cannabinoid-containing natural extracts. Solmic’s proprietary technology provides higher bioavailability and stability compared to alternative oil-based formulations. Solmic’s technology allows active ingredients to become water soluble without changing their composition and nature. To view the full article, visit http://nnw.fm/0IFyu About Pivot Pharmaceuticals Inc. Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks